ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 171 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2019. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,107,391 | +47.4% | 1,125,032 | +90.7% | 3.81% | +78.6% |
Q2 2023 | $27,214,993 | +187.8% | 589,963 | +150.2% | 2.13% | +150.6% |
Q1 2023 | $9,454,658 | -12.9% | 235,777 | +0.6% | 0.85% | -15.6% |
Q4 2022 | $10,855,073 | -42.2% | 234,299 | -48.4% | 1.01% | -47.0% |
Q3 2022 | $18,792,000 | -30.4% | 453,794 | +0.3% | 1.90% | -39.4% |
Q2 2022 | $26,994,000 | -15.0% | 452,470 | +3.4% | 3.14% | +12.1% |
Q1 2022 | $31,772,000 | -8.1% | 437,512 | +6.4% | 2.80% | +13.1% |
Q4 2021 | $34,587,000 | -13.1% | 411,313 | -6.8% | 2.48% | -5.5% |
Q3 2021 | $39,788,000 | +82.0% | 441,159 | +92.4% | 2.62% | +99.9% |
Q2 2021 | $21,859,000 | -11.7% | 229,246 | +5.4% | 1.31% | -20.2% |
Q1 2021 | $24,760,000 | -16.4% | 217,459 | +1.7% | 1.64% | -25.0% |
Q4 2020 | $29,608,000 | +94.8% | 213,887 | +15.6% | 2.19% | +40.6% |
Q3 2020 | $15,203,000 | -18.0% | 184,970 | -21.9% | 1.56% | -27.9% |
Q2 2020 | $18,535,000 | +21.8% | 236,958 | -30.8% | 2.16% | -16.9% |
Q1 2020 | $15,222,000 | +104.3% | 342,603 | +96.4% | 2.60% | +173.0% |
Q4 2019 | $7,450,000 | -3.1% | 174,437 | -2.9% | 0.95% | -18.1% |
Q3 2019 | $7,686,000 | -32.8% | 179,659 | -0.2% | 1.16% | -26.8% |
Q2 2019 | $11,431,000 | – | 180,017 | – | 1.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |